000 01320nam a2200493 a 4500
001 vtls000025880
003 VRT
005 20240802184153.0
008 1012060814s1991 enk 00000 eng d
020 _a043443924X :
_c£16.99
035 _a(OCoLC)ocm24752080
035 _aAUZ-2903
035 _aVNU990033886
039 9 _a201608181650
_bhaianh
_c201502072044
_dVLOAD
_c201404250031
_dVLOAD
_y201012061857
_zVLOAD
040 _aVNU
041 _aeng
044 _aGB
082 1 4 _a338.7
_bLYN 1991
_214
090 _a338.7
_bLYN 1991
094 _a65.8
095 _a33(T)2
100 1 _aLynn, Matthew
245 1 4 _aThe Billion dollar battle :
_bMerck v Glaxo /
_cMatthew Lynn
260 _aLondon :
_bWilliam Heinemann,
_c1991
300 _a244 p. ;
_c24 cm
610 2 0 _aGlaxo Group Research Limited.
610 2 0 _aMerck & Co.
650 0 _aCompetition
650 0 _aDrugs
_xMarketing
650 0 _aPharmaceutical industry
650 0 _aPharmaceutical industry
_xMoral and ethical aspects
653 _aCông nghiệp dược phẩm
653 _aCạnh tranh
653 _aDoanh Nghiệp
653 _aTiếp thị
900 _aTrue
911 _aV.B.Linh
913 _aLê Thị Thanh Hậu
925 _aG
926 _a0
927 _aSH
928 _aAV-D2/00460
942 _c1
999 _c334584
_d334584